These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 30710391)

  • 1. Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.
    Family N; Maillet EL; Williams LTJ; Krediet E; Carhart-Harris RL; Williams TM; Nichols CD; Goble DJ; Raz S
    Psychopharmacology (Berl); 2020 Mar; 237(3):841-853. PubMed ID: 31853557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biperiden Challenge Model in Healthy Elderly as Proof-of-Pharmacology Tool: A Randomized, Placebo-Controlled Trial.
    Bakker C; van Esdonk MJ; Stuurman RFE; Borghans LGJM; de Kam ML; van Gerven JMA; Groeneveld GJ
    J Clin Pharmacol; 2021 Nov; 61(11):1466-1478. PubMed ID: 34021607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil protects hippocampal neurons by suppressing excessive autophagy and apoptosis in mice with sleep deprivation.
    Cao Y; Li Q; Liu L; Wu H; Huang F; Wang C; Lan Y; Zheng F; Xing F; Zhou Q; Li Q; Shi H; Zhang B; Wang Z; Wu X
    Br J Pharmacol; 2019 May; 176(9):1282-1297. PubMed ID: 30767208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs.
    Ferreira GS; Dijkstra FM; Veening-Griffioen DH; Boon WPC; Schellekens H; Moors EHM; van Meer PJK; Stuurman FE; van Gerven JMA
    Transl Psychiatry; 2023 Mar; 13(1):74. PubMed ID: 36859342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers.
    Dijkstra F; O'Donnell P; Klaassen E; Buhl D; Asgharnejad M; Rosen L; Zuiker R; van Gerven J; Jacobs G
    Transl Psychiatry; 2022 Sep; 12(1):408. PubMed ID: 36153330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies.
    Lon HK; Mendonca N; Goss S; Othman AA; Locke C; Jin Z; Rendenbach-Mueller B
    Clin Pharmacol Drug Dev; 2019 Apr; 8(3):290-303. PubMed ID: 30052328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers.
    Baakman AC; Zuiker R; van Gerven JMA; Gross N; Yang R; Fetell M; Gershon A; Gilgun-Sherki Y; Hellriegel E; Spiegelstein O
    Br J Clin Pharmacol; 2019 May; 85(5):970-985. PubMed ID: 30710391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects.
    Spiegelstein O; Stevens J; Van Gerven J; Nathan PJ; Maynard JP; Mayleben DW; Hellriegel E; Yang R
    J Psychopharmacol; 2016 Oct; 30(10):983-93. PubMed ID: 27222271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Chan Kwong A; Cassé-Perrot C; Costes-Salon MC; Jouve E; Lanteaume L; Audebert C; Rouby F; Lefebvre MN; Ranjeva JP; Beck A; Deplanque D; Ponchel A; Vervueren C; Truillet R; Babilon C; Auffret A; Richardson JC; Payoux P; Bartrés-Faz D; Blin O; Bordet R; Micallef J;
    J Clin Psychopharmacol; 2020; 40(3):222-230. PubMed ID: 32332458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers.
    James LM; Iannone R; Palcza J; Renger JJ; Calder N; Cerchio K; Gottesdiener K; Hargreaves R; Murphy MG; Boyle J; Dijk DJ
    Psychopharmacology (Berl); 2011 Jun; 215(4):643-53. PubMed ID: 21301819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEP-26401 (irdabisant), a potent and selective histamine H₃ receptor antagonist/inverse agonist with cognition-enhancing and wake-promoting activities.
    Raddatz R; Hudkins RL; Mathiasen JR; Gruner JA; Flood DG; Aimone LD; Le S; Schaffhauser H; Duzic E; Gasior M; Bozyczko-Coyne D; Marino MJ; Ator MA; Bacon ER; Mallamo JP; Williams M
    J Pharmacol Exp Ther; 2012 Jan; 340(1):124-33. PubMed ID: 22001260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of modafinil on working memory processes in humans.
    Müller U; Steffenhagen N; Regenthal R; Bublak P
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):161-9. PubMed ID: 15221200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.
    Harding SD; Sharman JL; Faccenda E; Southan C; Pawson AJ; Ireland S; Gray AJG; Bruce L; Alexander SPH; Anderton S; Bryant C; Davenport AP; Doerig C; Fabbro D; Levi-Schaffer F; Spedding M; Davies JA;
    Nucleic Acids Res; 2018 Jan; 46(D1):D1091-D1106. PubMed ID: 29149325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First in human study with a prodrug of galantamine: Improved benefit-risk ratio?
    Baakman AC; 't Hart E; Kay DG; Stevens J; Klaassen ES; Maelicke A; Groeneveld GJ
    Alzheimers Dement (N Y); 2016 Jan; 2(1):13-22. PubMed ID: 29067291
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.